Zoetis is a holding company. Through its subsidiaries, Co. develops, manufactures and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests and animal health technology. Co.'s product categories include: vaccines, which are biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; and parasiticides, which are products that prevent or eliminate parasites. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision animal health.
When researching a stock like Zoetis, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ZTS Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ZTS stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the ZTS 200 day moving average ("ZTS 200 DMA"), while one of the most popular "shorter look-backs" is the ZTS 50 day moving average ("ZTS 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Zoetis. |
Free ZTS Email Alerts:
Video: Technical Analysis